• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags Quadria Capital

Quadria Capital News

Business

Aragen Life Science Secures $100 Million Boost from Quadria Capital for Strategic Expansion

Michael Lee 13 Jan, 2025

Aragen Life Science secures a $100 million investment from Quadria Capital, aiming to expand its capabilities and infrastructure to meet global pharmaceutical outsourcing demands. ...

Popular News

  • Market

    Asia-Pacific Markets Dip Amid Geopolitical Tensions Despite US Inflation Ease

    13 Mar, 2025
  • Market

    European Markets React Mixed to Upcoming Steel and Aluminum Tariffs Impact

    12 Feb, 2025
  • Business

    Anticipating Union Budget 2025: Key Expectations from the Travel and Tourism Industry for Growth

    26 Jan, 2025
  • Business

    Trump's Tariff Exemption Boosts India's Pharma Sector: A Win for Affordable Healthcare

    03 Apr, 2025
  • Market

    Tesla Shares Tumble 5% Premarket After China Slaps 34% Tariff on US Imports

    04 Apr, 2025
  • Business

    Indian Rupee Set to Strengthen: Key Factors Driving Its Appreciation Against the US Dollar

    03 May, 2025
  • Economy

    Goldman Sachs Slashes Oil Price Forecast Amidst Tariff Wars and OPEC Supply Surge

    17 Mar, 2025
  • Business

    US Eyes Major Policy Shifts in India Trade Deal: Tariff Cuts and Regulatory Reforms on the Table

    05 May, 2025

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.